TALAL KHAN: Open Payments
NPI 1861406613 · EAST LONG MEADOW, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,046 in 84 payments from 19 companies in 2025. Trend: 2023 $2,958 · 2024 $2,734 · 2025 $2,046
Food & beverage: $2,046
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $691 |
| Phathom Pharmaceuticals, Inc. | 12 | $277 |
| Lilly USA, LLC | 4 | $152 |
| Axsome Therapeutics, Inc. | 3 | $141 |
| GlaxoSmithKline, LLC. | 7 | $140 |
| Novo Nordisk Inc | 5 | $108 |
| AstraZeneca Pharmaceuticals LP | 4 | $103 |
| Astellas Pharma US Inc | 3 | $91 |
| Abbott Laboratories | 3 | $78 |
| Antares Pharma, Inc. | 2 | $45 |
Products named: UBRELVY, VOQUEZNA, VRAYLAR, KISUNLA, Auvelity, Veozah, TRELEGY ELLIPTA, FREESTYLE LIBRE 3.
Industry payments across MA — which companies pay providers there.
